ICOS Immune Checkpoint


ICOS belongs to the CD28 and CTLA-4 cell-surface receptor family. It forms homodimers and plays an important role in cell-cell signaling, immune responses, and regulation of cell proliferation.

Risk-Free™ ICOS Antibody Development Progress

ProSci's Risk-Free™ antibodies are monoclonal antibodies made to improve in vitro studies. Unlike antibodies developed using proteins made in yeast or bacteria, Risk-Free™ antibodies are developed with antigens expressed in mammalian cell lines, giving the most native post-translational modifications to the protein. Risk-Free™ means they are guaranteed to work for their approved applications.

Risk-Free™ Mouse Monoclonal ICOS Antibodies

  • ImmunizationPhase Duration:
    About 2 to 3 months
  • FusionPhase Duration:
    About 1 to 2 months
  • CloningPhase Duration:
    About 2 to 3 months
  • ValidationPhase Duration:
    About 1 month
  • Release

Have Questions About Our ICOS Antibody?

I am NOT interested in receiving promotions, discounts or news.